Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal Study

Blood (2024) 144 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2024-204788

Published: 2024

Journal Articles

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Blood (2022) 140 (Supplement 1): 8503–8504.

https://doi.org/10.1182/blood-2022-158549

Published: 2022

Journal Articles

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Grigorios Tsaknakis, Stavros Papadakis, Peggy Kanellou, Irene Mavroudi, Irene Fragiadaki, Charalampos Pontikoglou, Anna Gallì, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (Supplement 1): 987.

https://doi.org/10.1182/blood-2021-151131

Published: 2021

Journal Articles

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Blood (2021) 138 (Supplement 1): 1535.

https://doi.org/10.1182/blood-2021-149630

Published: 2021

Journal Articles

Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever ( MEFV ) in a Cohort of Patients with Chronic Idiopathic Neutropenia

Panagiotis Skendros, Irene Mavroudi, Stavros Papadakis, Peggy Kanellou, Erasmia Boutakoglou, Grigorios Tsaknakis, Charalampos Pontikoglou, George Goulielmos, Konstantinos Ritis, Helen A. Papadaki

Blood (2021) 138 (Supplement 1): 3124.

https://doi.org/10.1182/blood-2021-150072

Published: 2021

Journal Articles

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Grigorios Tsaknakis, Anna Gallì, Stavros Papadakis, Peggy Kanellou, Chiara Elena, Gabriele Todisco, Elisa Bono, Ettore Rizzo, Elisabetta Molteni, Irene Fragiadaki, Irene Mavroudi, Charalampos Pontikoglou, Anastasios Batas, Stella Maxouri, Emmanouela Linardaki, Nektarios Tavernarakis, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (14): 1249–1257.

https://doi.org/10.1182/blood.2021010815

Published: 2021

Includes: Supplemental data

Journal Articles

Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)

Nikoleta Bizymi, MD MSc, Athina Damianaki, Maria Velegraki, MD PhD, Konstantina Zavitsanou, MSc, Anastasios Karasachinidis, Anthie Georgopoulou, PhD, Irene Mavroudi, PhD, John Sperelakis, MD, George Kontakis, MD PhD, Charalampos Pontikoglou, MD PhD, Helen A. Papadaki, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136500

Published: 2020

Journal Articles

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Elena E. Solomou, MD, Alexandra Kourakli, MD PhD, Anna Vardi, MD PhD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, MD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Aikaterini Palla, Athina Vyniou, Charalampos Pontikoglou, MD PhD, Panagiotis T Diamantopoulos, MD PhD, Theodoros Vassilakopoulos, MD, Aikaterini Megalakaki, Eleni Variami, Helen A. Papadaki, MD PhD, George Vassilopoulos, MD PhD, Achilles Anagnostopoulos, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 5417.

https://doi.org/10.1182/blood-2019-131003

Published: 2019

Journal Articles

Systemic Mastocytosis: Management and Outcome. Data Analysis from the Greek Registry

Ioannis Tsonis, MD, Nikolaos Kanellias, MD, Vasileios Lazaris, Panayiotis Panayiotidis, MD PhD, Damianos Sotiropoulos, MD, Theodoros Vassilakopoulos, MD, Zoi Arapidou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Dimitrios Boutsis, Athanasios Galanopoulos, MD PhD, Ioannis Kotsianidis, MD PhD, Marie-Christine Kyrtsonis, MD PhD, Theoni Leonidopoulou, MD, Gerasimos Pangalis, MD, Maria Papaioannou, Sophia Polychronopoulou, MD PhD, Charalampos Pontikoglou, MD PhD, Elias Poulakidas, Christos Poziopoulos, MD, Panagiotis Repousis, MD, Maria Topalidou, Kalliopi Vallianatou, Elina Vervessou, MD, Nora-Athina Viniou, Maria Angelopoulou, MD, Ioannis Baltadakis, MD, Maria Dimou, MD PhD, Eleni Gavriilaki, MD, Theodoros Iliakis, MD, Argiris Symeonidis, MD PhD, Sossana Delibasi, MD, Maria Papathanassiou, Theodoros Marinakis, Panagiotis Tsirigotis, MD, Nikolaos Charchalakis, PhD, Evangelos Terpos, MD PhD, Maria Pagoni

Blood (2018) 132 (Supplement 1): 5463.

https://doi.org/10.1182/blood-2018-99-116693

Published: 2018

Journal Articles

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Evdoxia Kamouza, Christos K. Kontos, PhD, Argiris Symeonidis, MD PhD, Vassiliki Pappa, MD, Alexandra Kourakli, MD PhD, Nora-Athina Viniou, MD, Sotirios Papageorgiou, MD PhD, Charalampos Pontikoglou, Menelaos Konstantinos Papoutselis, Helen A. Papadaki, MD PhD, Eleftheria Hatzimichael, Panagiotis Zikos, Dr, Maria Dimou, Panayiotis Panayiotidis, MD PhD, Dimitrios Tsokanas, Despina Mparmparousi, Flora Kontopidou, Eleni Variami, Panagiotis Repousis, MD, Elias Poulakidas, Dimitrios Christoulas, MD, Theodoros Vassilakopoulos, MDPhD, Michael Voulgarelis, MD PhD, Aikaterini Megalakaki, Maria Kotsopoulou, Giorgos Karianakis, Despina Kaliontzi, Ioannis Adamopoulos, MD, Maria Dalekou, Anastasia Sioni, Maria Papaioannou, Dimitrios Gogos, Panagiotis Theodorou Diamantopoulos, MD PhD, Elena E. Solomou, MD, Ioannis Kotsianidis, PhD

Blood (2018) 132 (Supplement 1): 1822.

https://doi.org/10.1182/blood-2018-99-119531

Published: 2018

Journal Articles

The Effect of 5-Azacitidine Treatment on the Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Ioannis Liapis, Aristea Batsali, Anastasios Mitrakos, Elisavet Kouvidi, Athanasios Galanopoulos, MD PhD, Charalampos Pontikoglou, MD PhD, Emmanouil Kanavakis, Helen A. Papadaki, MD PhD

Blood (2017) 130 (Supplement 1): 4242.

https://doi.org/10.1182/blood.V130.Suppl_1.4242.4242

Published: 2017

Journal Articles

Demographic, Clinical and Laboratory Features, Management and Outcome of Immune Thrombocytopenia (ITP) in Greece: The National ITP Registry of the Hellenic Society of Hematology

Blood (2017) 130 (Supplement 1): 4859.

https://doi.org/10.1182/blood.V130.Suppl_1.4859.4859

Published: 2017

Journal Articles

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Argiris Symeonidis, MD PhD, Alexandra Kourakli, MD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, Eleftheria Hatzimichael, Theodoros Vassilakopoulos, MDPhD, Aikaterini Palla, Vassiliki Pappa, MD, Evgenia Verigou, Zafeirios Kartasis, MD, Eirini Katodritou, Maria Pagoni, Theodora Assimakopoulou, Charalampos Pontikoglou, MD PhD, Maria Dimou, George Xanthopoulidis, Maria K. Angelopoulou, MD, Maria Kotsopoulou, Dimitra Liapi, Despina Mparmparousi, Evridiki Michali, Anna Kioumi, Nora-Athina Viniou, Achilles Anagnostopoulos, Vassiliki Labropoulou, Maria Dalekou, Michael Voulgarelis, MD PhD, Efthymia Vlachaki, Anna Christoforidou, Ioannis Adamopoulos, MD, Akrivi Kostourou, Petros Laos, Evangelos Terpos, MD PhD, Eleni Kapsali, George Vassilopoulos, MD PhD, Helen A. Papadaki, MD PhD, Panayiotis Panayiotidis, MD PhD, Athanasios Galanopoulos, MD PhD

Blood (2017) 130 (Supplement 1): 1696.

https://doi.org/10.1182/blood.V130.Suppl_1.1696.1696

Published: 2017

Journal Articles

Bone Marrow Derived Mesenchymal Stem Cells from Splenic Marginal Zone Lymphoma Patients Exhibit Altered Proliferative Potential and B Lymphocyte Immunomodulatory Properties

Athanasia Kalyva, PhD, Charalampos Pontikoglou, MD PhD, Christina Kalpadakis, MD PhD, Athina Trakaki, Nikitas Zorzos, Maria Velegraki, MD PhD, Grigorios Panteloglou, Kallliopi Alpantaki, MDPhD, Gerasimos A. Pangalis, MD PhD, Helen A Papadaki, MDPhD

Blood (2015) 126 (23): 2396.

https://doi.org/10.1182/blood.V126.23.2396.2396

Published: 2015

Journal Articles

Increased Frequency of Paroxysmal Nocturmal Hemoglobinuria Type Cells in Patients with Chronic Idiopathic Neutropenia Correlates with the Severity of the Disease and the Presence of Skewed T-Cell Expansions

Athena Damianaki, Elias Stagakis, MD PhD, Semeli Mastrodemou, Irene Mavroudi, PhD, Maria Velegraki, MD PhD, Helen Koutala, Peggy Kanellou, MD PhD, Charalampos Pontikoglou, MD PhD, Helen A. Papadaki, MD PhD

Blood (2015) 126 (23): 4778.

https://doi.org/10.1182/blood.V126.23.4778.4778

Published: 2015

Journal Articles

Emerging Roles of Wisp-1 and SFRP4 in Proliferation and Differentiation Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells

Aristea Batsali, Charalampos Pontikoglou, Emmanuel Agrafiotis, Elisavet Kouvidi, Irene Mavroudi, Athina Damianaki, Maria-Christina Kastrinaki, Helen Papadaki

Blood (2014) 124 (21): 4375.

https://doi.org/10.1182/blood.V124.21.4375.4375

Published: 2014

Journal Articles

Comparative Analysis Of Bone Marrow and Wharton’s Jelly Mesenchymal Stem/Stromal Cells

Aristea Batsali, Charalampos Pontikoglou, Elisavet Kouvidi, Athina Damianaki, Aikaterini Stratigi, Maria-Christina Kastrinaki, Helen A Papadaki

Blood (2013) 122 (21): 1212.

https://doi.org/10.1182/blood.V122.21.1212.1212

Published: 2013

Journal Articles

A Novel Role of NF-YA Transcription Factor in in Vitro Adipocyte Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells

Charalampos Pontikoglou, Anthi Demetriadou, Konstantia I. Pavlaki, Emmanouil Simantirakis, Joseph Papamatheakis, Maria-Christina Kastrinaki, Helen Papadaki

Blood (2012) 120 (21): 1250.

https://doi.org/10.1182/blood.V120.21.1250.1250

Published: 2012

Journal Articles

Study of the Quantitative, Functional, Cytogenetic and Immunoregulatory Properties of Bone Marrow Mesenchymal Stem Cells in Patients with B-Cell Chronic Lymphocytic Leukemia

Charalampos Pontikoglou, Maria-Christina Kastrinaki, Mirjam Klaus, Christina H. Kalpadakis, Pavlos Katonis, Kalliopi Alpantaki, Gerasimos Pangalis, Helen Papadaki

Blood (2012) 120 (21): 3861.

https://doi.org/10.1182/blood.V120.21.3861.3861

Published: 2012

Journal Articles

Impaired Wnt-Pathway Signalling and Reduced Expression of Senescence-Associated Markers in Bone Marrow Mesenchymal Stem Cells of Patients with Myelodysplastic Syndromes

Konstantia I. Pavlaki, Maria-Christina Kastrinaki, Aristea Batsali, Anthi Demetriadou, Maria Velegraki, Irene Mavroudi, Michael Klontzas, Anna Psaraki, Maria Psyllaki, Charalampos Pontikoglou, Helen A. Papadaki

Blood (2011) 118 (21): 272.

https://doi.org/10.1182/blood.V118.21.272.272

Published: 2011

NARROW

Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal Study

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever ( MEFV ) in a Cohort of Patients with Chronic Idiopathic Neutropenia

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Systemic Mastocytosis: Management and Outcome. Data Analysis from the Greek Registry

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

The Effect of 5-Azacitidine Treatment on the Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Demographic, Clinical and Laboratory Features, Management and Outcome of Immune Thrombocytopenia (ITP) in Greece: The National ITP Registry of the Hellenic Society of Hematology

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Bone Marrow Derived Mesenchymal Stem Cells from Splenic Marginal Zone Lymphoma Patients Exhibit Altered Proliferative Potential and B Lymphocyte Immunomodulatory Properties

Increased Frequency of Paroxysmal Nocturmal Hemoglobinuria Type Cells in Patients with Chronic Idiopathic Neutropenia Correlates with the Severity of the Disease and the Presence of Skewed T-Cell Expansions

Emerging Roles of Wisp-1 and SFRP4 in Proliferation and Differentiation Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells

Comparative Analysis Of Bone Marrow and Wharton’s Jelly Mesenchymal Stem/Stromal Cells

A Novel Role of NF-YA Transcription Factor in in Vitro Adipocyte Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells

Study of the Quantitative, Functional, Cytogenetic and Immunoregulatory Properties of Bone Marrow Mesenchymal Stem Cells in Patients with B-Cell Chronic Lymphocytic Leukemia

Impaired Wnt-Pathway Signalling and Reduced Expression of Senescence-Associated Markers in Bone Marrow Mesenchymal Stem Cells of Patients with Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only